Risk factors for antibiotic re-administration in patients with pneumonia during hospitalization.

S. Nishizawa (Fukuoka, Japan), K. Tobino (Fukuoka, Japan), M. Okahisa (Fukuoka, Japan), Y. Goto (Fukuoka, Japan), K. Murakami (Fukuoka, Japan), T. Sueyasu (Fukuoka, Japan), M. Munechika (Fukuoka, Japan), K. Yoshimine (Fukuoka, Japan)

Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia
Session: Improving the outcomes of community-acquired pneumonia
Session type: Poster Discussion
Number: 2038
Disease area: Respiratory infections

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Nishizawa (Fukuoka, Japan), K. Tobino (Fukuoka, Japan), M. Okahisa (Fukuoka, Japan), Y. Goto (Fukuoka, Japan), K. Murakami (Fukuoka, Japan), T. Sueyasu (Fukuoka, Japan), M. Munechika (Fukuoka, Japan), K. Yoshimine (Fukuoka, Japan). Risk factors for antibiotic re-administration in patients with pneumonia during hospitalization.. 2038

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Risk factors of nosocomial pneumonia in multiple trauma patients
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018


Timing of antibiotic administration and outcomes for patients with community-acquired pneumonia (CAP). NAC-CV Study
Source: Eur Respir J 2006; 28: Suppl. 50, 349s
Year: 2006

Risk factors of treatment failure of community acquired pneumonia in patients with COPD
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia
Source: Eur Respir J 2009; 33: 153-159
Year: 2009



Impact of reducing antibiotic treatment on inflammation among patients with community-acquired pneumonia.
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019


Causes and predictors of treatment failures in patients with ICU-acquired pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 16s
Year: 2002

Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP
Source: Eur Respir J 2013; 41: 123-130
Year: 2013



Prolonged hospitalization in community-acquired pneumonia. Influence of clinical factors and hospital characteristics
Source: Eur Respir J 2003; 22: Suppl. 45, 544s
Year: 2003

Incidence, risk factors and outcomes of cardiovascular events in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009

Risk factors of postoperative nosocomial pneumonia after lung-resection
Source: Annual Congress 2007 - Pulmonary infections and inflammation
Year: 2007


Risk factors for long-term hospitalization in patients with COVID 19
Source: Virtual Congress 2021 – COVID - 19 epidemiology
Year: 2021


Risk factors for bacterial infection in exacerbated COPD requiring admission
Source: Eur Respir J 2001; 18: Suppl. 33, 153s
Year: 2001

Risk factors of mortality in COPD patients with ventilator associated pneumonia
Source: Eur Respir J 2007; 30: Suppl. 51, 50s
Year: 2007

Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia
Source: Eur Respir J 2010; 36: 128-134
Year: 2010



Risk factors and implications for readmission of patients following hospitalization for community-acquired pneumonia in South Korea
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019


Reducing unnecessary antibiotic use and hospitalization in children with pneumonia
Source: International Congress 2019 – Epidemiology of childhood respiratory diseases
Year: 2019


Predictive factors of in-hospital mortality of patients with community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 352s
Year: 2006

The impact of empiric antibacterial therapy on mortality for patients hospitalized with community-acquired pneumonia (CAP)
Source: Eur Respir J 2006; 28: Suppl. 50, 733s
Year: 2006

Risk factors for early onset severe community-acquired pneumonia complications
Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ?
Year: 2018




Risk factors for ICU acquired pneumonia
Source: Annual Congress 2008 - Acute lung injury and weaning
Year: 2008